T. Rowe Price Associates
AXGN icon

T. Rowe Price Associates’s Axogen AXGN Stock Holding History

T. Rowe Price Associates’s Portfolio AXGN Stock Details AXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47M Buy
1,018,042
+967,257
+1,905% +$39M ﹤0.01% 910
2026
Q1 		$1.68M Buy
50,785
+7,230
+17% +$235K ﹤0.01% 1907
2025
Q4 		$1.43M Buy
43,555
+2,894
+7% +$71.2K ﹤0.01% 1916
2025
Q3 		$726K Buy
40,661
+1,259
+3% +$18.3K ﹤0.01% 2208
2025
Q2 		$428K Buy
39,402
+3,401
+9% +$44.6K ﹤0.01% 2374
2025
Q1 		$667K Buy
36,001
+1,181
+3% +$21.3K ﹤0.01% 2141
2024
Q4 		$574K Buy
34,820
+3,220
+10% +$45.6K ﹤0.01% 2232
2024
Q3 		$444K Buy
31,600
+427
+1% +$4.72K ﹤0.01% 2305
2024
Q2 		$226K Buy
31,173
+1,523
+5% +$10.4K ﹤0.01% 2543
2024
Q1 		$240K Buy
29,650
+2,204
+8% +$19.7K ﹤0.01% 2534
2023
Q4 		$188K Sell
27,446
-3,822
-12% -$21.3K ﹤0.01% 2562
2023
Q3 		$157K Buy
31,268
+9,504
+44% +$65.8K ﹤0.01% 2566
2023
Q2 		$199K Buy
21,764
+180
+0.8% +$1.68K ﹤0.01% 2535
2023
Q1 		$204K Sell
21,584
-1
-0% -$9 ﹤0.01% 2517
2022
Q4 		$215K Buy
21,585
+830
+4% +$9.22K ﹤0.01% 2498
2022
Q3 		$248K Buy
20,755
+2,526
+14% +$25.3K ﹤0.01% 2465
2022
Q2 		$149K Sell
18,229
-334
-2% -$2.85K ﹤0.01% 2669
2022
Q1 		$147K Buy
18,563
+7,683
+71% +$66.4K ﹤0.01% 2774
2021
Q4 		$102K Sell
10,880
-445
-4% -$5.34K ﹤0.01% 2870
2021
Q3 		$179K Sell
11,325
-100
-0.9% -$1.8K ﹤0.01% 2749
2021
Q2 		$247K Buy
11,425
+825
+8% +$16.7K ﹤0.01% 2649
2021
Q1 		$215K Buy
+10,600
New +$209K ﹤0.01% 2669
2016
Q1 		– Sell
-75,914
Closed -$380K – 2506
2015
Q4 		$380K Buy
+75,914
New +$375K ﹤0.01% 2067

Other funds holding AXGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

T. Rowe Price Associates's AXGN Position: Q2 2026 in Review

T. Rowe Price Associates increased its Axogen (AXGN) stake by 1,905% in Q2 2026, buying an estimated $39M and bringing the position to 1,018,042 shares worth $47M. The position accounts for ﹤0.01% of the portfolio, ranked #910.

T. Rowe Price Associates first reported a position in AXGN in Q4 2015 and has held it in 23 quarters since. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • T. Rowe Price Associates held 1,018,042 shares of Axogen worth $47M as of Q2 2026.
  • T. Rowe Price Associates bought 967,257 Axogen shares in Q2 2026, an estimated $39M.
  • Axogen made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #910 holding.
  • T. Rowe Price Associates first reported a position in Axogen in Q4 2015 and has held it in 23 quarters since.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.